NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/24/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization56.6 mln
Float42.82 mln
Earnings Date08/12/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
5.38
Transformational upside
Relative Strength
28
/ 100
Underperforming
Debt / Equity
0.00
Debt-free
ROE
-55.97
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Context Therapeutics is a Philadelphia-based drug development company focused on finding new ways to treat solid tumor cancers. Its main drug candidate, CTIM-76, is designed to harness the body's own immune cells to seek out and destroy cancer cells that carry a specific protein called Claudin 6. The company works alongside Integral Molecular to advance this approach through a shared licensing and development agreement.
